In November, we continued our tradition of supporting ZERO Prostate Cancer's Grow & Give campaign to raise awareness about prostate cancer. This year, we pledged to increase our end-of-month donation for every share of our Grow And Give social posts, with all proceeds going toward supporting ZERO’s mission to raise awareness and ultimately end prostate cancer. A big thank you to everyone who participated — your support has made a meaningful impact in the fight against #prostatecancer. Don’t forget, ZERO Prostate Cancer is matching donations until 12/31, doubling the impact of contributions to provide critical support for prostate cancer patients and those at risk. Learn more here: https://hubs.la/Q02_RHB90
Cleveland Diagnostics
Biotechnology Research
Cleveland, Ohio 2,110 followers
Cleveland Diagnostics is a cancer biotechnology company that is changing the shape of cancer detection
About us
Cleveland Diagnostics has unlocked the diagnostic power of protein structure with its revolutionary IsoClear™ platform to develop novel diagnostics based on protein structure-based assessment.
- Website
-
http://www.clevelanddx.com
External link for Cleveland Diagnostics
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Cleveland, Ohio
- Type
- Privately Held
- Founded
- 2013
- Specialties
- prostate cancer, cancer diagnostics, and IsoPSA
Locations
-
Primary
3615 Superior Avenue
Cleveland, Ohio 44114, US
Employees at Cleveland Diagnostics
-
Chris Fox
Vice President of Marketing at Cleveland Diagnostics, Inc.
-
Andrew Summers
Chief Financial Officer | Strategic Investments & Advisory
-
Maital (Shemesh) Rasmussen
Chief Commercial Officer | Board Director | Health-Tech Executive | Growth and Revenue at Scale | Octave, Roche, Oracle…
-
Bob Rochelle
Chief Commercial Officer at Cleveland Diagnostics
Updates
-
IsoPSA, whether used with or without mpMRI, delivers clear insights to support shared decision-making in #cancer care. Learn more about the IsoPSA experience at: https://hubs.la/Q02_RzKC0 #prostatehealth
-
#DidYouKnow that PSA levels can increase due to benign factors like prostate enlargement, infections, sexual activity, or even a prostate exam? IsoPSA reduces unnecessary prostate biopsies by providing a clearer, more accurate assessment of #prostate cancer risk. It helps to identify patients with cancer—and those without—supporting more informed decision-making. Learn more: https://hubs.la/Q02_Rvv20
-
#Prostatecancer can cause PSA levels to increase, but so can benign factors. Assessing the structure of PSA is a more specific and direct measure of #cancer that can help determine if PSA originated from cancer cells. Learn more at https://hubs.la/Q02-KLB_0
-
IsoPSA offers a novel approach to identifying prostate cancer by analyzing PSA protein structure. By analyzing the structure of PSA proteins to determine if cancer is present, IsoPSA can help identify individuals who may not benefit from undergoing a prostate biopsy. Learn more: https://hubs.la/Q02-KvqB0
-
Hard to believe we are just three months away from #GU25! Early this year at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium researchers including Tarik Benidir, M.D., urologic oncologist at UF Health, presented findings from a study evaluating the risk of #prostatecancer diagnosis in men with an elevated PSA but low IsoPSA. The findings suggest a low baseline IsoPSA provides durable information about the 2-year risk of clinically significant prostate cancer. The abstract is available via the Journal of Clinical Oncology: https://hubs.la/Q02-JKrX0
-
We’re on a mission to help detect #cancer earlier, when it’s most treatable and survivable. Read our story at https://hubs.ly/Q02-JVPZ0
-
Know the signs and get checked! Educating yourself on the common symptoms of prostate cancer can be the difference in beating the disease. Early detection is key, so contact your healthcare provider if you’re experiencing any of the signs. Throughout November, we’ve partnered with ZERO Prostate Cancer to raise awareness about prostate cancer. While we continue to GROW awareness, it’s almost time to GIVE to the cause – for every share of our Grow And Give posts, we’ll increase our end-of-month donation to the cause. https://hubs.la/Q02WVxpj0 #ZeroProstateCancer #ProstateCancer #GrowAndGive #ProstateCancerAwareness
-
By identifying structural differences in PSA proteins that are expressed from cancer, IsoPSA helps better inform biopsy decisions for patients with elevated PSA who have never undergone a biopsy or who have had a prior negative biopsy. Learn more about how IsoPSA offers simpler patient selection, significantly improved accuracy, and clear, easy-to-interpret results: https://hubs.la/Q02WVym80 #IsoPSA #prostatecancer
-
When it comes to prostate cancer, timing is everything. The relative survival rate of cases that are detected early is nearly 100%, but that number drops dramatically the longer you wait. Routine screenings can help identify prostate cancer early, and being prepared to ask your doctor the right questions can help you navigate the process with confidence. We’re working with ZERO Prostate Cancer to raise awareness about prostate cancer research. For every share of our Grow And Give posts, we’ll increase our end-of-month donation to the cause. https://hubs.la/Q02WV3860 #ZeroProstateCancer #ProstateCancerAwareness #GrowAndGive #ProstateCancer